2024 Q4 Form 10-Q Financial Statement

#000138865824000167 Filed on October 30, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3 2023 Q4
Revenue $147.5M $132.5M
YoY Change 18.41% 17.67%
Cost Of Revenue $46.06M $45.09M
YoY Change 9.33% 32.95%
Gross Profit $101.5M $87.43M
YoY Change 23.04% 11.08%
Gross Profit Margin 68.78% 65.98%
Selling, General & Admin $103.4M $98.34M
YoY Change 10.25% 13.39%
% of Gross Profit 101.87% 112.49%
Research & Development $15.69M $15.42M
YoY Change -3.77% 21.63%
% of Gross Profit 15.47% 17.63%
Depreciation & Amortization $5.100M $4.918M
YoY Change 24.39% 41.53%
% of Gross Profit 5.03% 5.63%
Operating Expenses $151.8M $113.8M
YoY Change 37.88% 14.44%
Operating Profit -$50.30M -$26.33M
YoY Change 82.24% 27.22%
Interest Expense $3.127M -$941.0K
YoY Change 237.32% -7.11%
% of Operating Profit
Other Income/Expense, Net $4.309M $1.679M
YoY Change 169.31% 5.86%
Pretax Income -$45.99M -$38.44M
YoY Change 70.85% 91.03%
Income Tax $188.0K $255.0K
% Of Pretax Income
Net Earnings -$46.18M -$38.70M
YoY Change 70.31% 91.6%
Net Earnings / Revenue -31.3% -29.2%
Basic Earnings Per Share -$1.48
Diluted Earnings Per Share -$1.48 -$1.26
COMMON SHARES
Basic Shares Outstanding 31.30M shares 31.24M shares 30.65M shares
Diluted Shares Outstanding 31.26M shares

Balance Sheet

Concept 2024 Q4 2024 Q3 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $522.0M $133.8M
YoY Change 229.41% -37.24%
Cash & Equivalents $519.5M $36.17M
Short-Term Investments $2.496M $97.59M
Other Short-Term Assets $13.42M $21.59M
YoY Change 10.9% 104.56%
Inventory $15.03M $13.97M
Prepaid Expenses
Receivables $77.43M $61.48M
Other Receivables $0.00 $0.00
Total Short-Term Assets $627.9M $230.8M
YoY Change 168.0% -20.07%
LONG-TERM ASSETS
Property, Plant & Equipment $122.4M $104.1M
YoY Change 26.61% 37.59%
Goodwill $862.0K $862.0K
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments $3.496M $3.000M
YoY Change
Other Assets $45.54M $48.04M
YoY Change -3.21% 115.89%
Total Long-Term Assets $281.8M $202.3M
YoY Change 37.13% 26.89%
TOTAL ASSETS
Total Short-Term Assets $627.9M $230.8M
Total Long-Term Assets $281.8M $202.3M
Total Assets $909.7M $433.1M
YoY Change 106.86% -3.36%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.593M $5.543M
YoY Change 5.28% -26.26%
Accrued Expenses $73.96M $83.36M
YoY Change -3.49% 27.28%
Deferred Revenue $3.000M $3.300M
YoY Change -11.76% 8.16%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00
YoY Change
Total Short-Term Liabilities $100.1M $107.4M
YoY Change -2.14% 20.51%
LONG-TERM LIABILITIES
Long-Term Debt $645.8M $34.95M
YoY Change 1748.05% 0.04%
Other Long-Term Liabilities $17.98M $1.012M
YoY Change 1674.73% -22.57%
Total Long-Term Liabilities $17.98M $35.96M
YoY Change -50.0% -0.77%
TOTAL LIABILITIES
Total Short-Term Liabilities $100.1M $107.4M
Total Long-Term Liabilities $17.98M $35.96M
Total Liabilities $837.9M $223.0M
YoY Change 280.92% 7.02%
SHAREHOLDERS EQUITY
Retained Earnings -$757.6M -$645.6M
YoY Change 24.82% 23.63%
Common Stock $854.4M $855.8M
YoY Change 3.35% 12.25%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $71.77M $210.1M
YoY Change
Total Liabilities & Shareholders Equity $909.7M $433.1M
YoY Change 106.86% -3.36%

Cashflow Statement

Concept 2024 Q4 2024 Q3 2023 Q4
OPERATING ACTIVITIES
Net Income -$46.18M -$38.70M
YoY Change 70.31% 91.6%
Depreciation, Depletion And Amortization $5.100M $4.918M
YoY Change 24.39% 41.53%
Cash From Operating Activities $24.35M -$15.97M
YoY Change 1928.92% -227.0%
INVESTING ACTIVITIES
Capital Expenditures $23.83M $13.51M
YoY Change 162.2% 90.53%
Acquisitions
YoY Change
Other Investing Activities -$31.50M $14.92M
YoY Change 396.06% -1560.82%
Cash From Investing Activities -$55.33M $1.401M
YoY Change 258.38% -117.27%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -35.00K 3.470M
YoY Change -158.33% 10.23%
NET CHANGE
Cash From Operating Activities 24.35M -15.97M
Cash From Investing Activities -55.33M 1.401M
Cash From Financing Activities -35.00K 3.470M
Net Change In Cash -31.02M -11.10M
YoY Change 118.77% -245.86%
FREE CASH FLOW
Cash From Operating Activities $24.35M -$15.97M
Capital Expenditures $23.83M $13.51M
Free Cash Flow $513.0K -$29.48M
YoY Change -106.5% -637.75%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Address Address Line1
EntityAddressAddressLine1
699 8th Street Suite 600
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
519535000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
15032000 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
13419000 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
627909000 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
122390000 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
45570000 usd
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-8149544
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001388658
dei Security12b Title
Security12bTitle
Common Stock, Par Value $0.001 Per Share
dei Trading Symbol
TradingSymbol
IRTC
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
31298034 shares
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
519535000 usd
dei Entity Registrant Name
EntityRegistrantName
iRhythm Technologies, Inc.
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
71766000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
210097000 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
909688000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
433144000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
124604000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
427514000 usd
CY2024Q3 us-gaap Cost Of Revenue
CostOfRevenue
46062000 usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
42130000 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
101476000 usd
CY2024Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
2496000 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
77427000 usd
CY2024Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
8358000 usd
CY2024Q3 us-gaap Goodwill
Goodwill
862000 usd
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31516000 shares
CY2023Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
97591000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
61484000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
13973000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
21591000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
230812000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
104114000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
49317000 usd
CY2023Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
0 usd
CY2023Q4 us-gaap Goodwill
Goodwill
862000 usd
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31287000 shares
CY2023Q3 us-gaap Gross Profit
GrossProfit
82474000 usd
us-gaap Net Income Loss
NetIncomeLoss
-84707000 usd
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Entity File Number
EntityFileNumber
001-37918
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
36173000 usd
CY2024Q3 us-gaap Long Term Investments
LongTermInvestments
59059000 usd
CY2023Q4 us-gaap Long Term Investments
LongTermInvestments
3000000 usd
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
45540000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
45039000 usd
CY2024Q3 us-gaap Assets
Assets
909688000 usd
CY2023Q4 us-gaap Assets
Assets
433144000 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
7593000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5543000 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
73958000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
83362000 usd
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3031000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3306000 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
15522000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
15159000 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
100104000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
107370000 usd
CY2024Q3 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
645821000 usd
CY2023Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
0 usd
CY2024Q3 us-gaap Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
0 usd
CY2023Q4 us-gaap Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
34950000 usd
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
17978000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1012000 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
74019000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
79715000 usd
CY2024Q3 us-gaap Liabilities
Liabilities
837922000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
223047000 usd
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
30954000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
30954000 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
31000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
31000 usd
CY2024Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
854363000 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
855784000 usd
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-66000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-112000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-757562000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-645606000 usd
CY2024Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
229000 shares
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
0 shares
CY2024Q3 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
25000000 usd
CY2023Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
0 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
147538000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
360170000 usd
us-gaap Cost Of Revenue
CostOfRevenue
135051000 usd
us-gaap Cost Of Revenue
CostOfRevenue
115790000 usd
us-gaap Gross Profit
GrossProfit
292463000 usd
us-gaap Gross Profit
GrossProfit
244380000 usd
CY2024Q3 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
15694000 usd
CY2023Q3 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
16309000 usd
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
52378000 usd
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
44828000 usd
CY2024Q3 us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
32069000 usd
CY2023Q3 us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
0 usd
us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
32069000 usd
us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
0 usd
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
103375000 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
93768000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
318797000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
285531000 usd
CY2024Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
641000 usd
CY2023Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
641000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
151779000 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
110077000 usd
us-gaap Operating Expenses
OperatingExpenses
403885000 usd
us-gaap Operating Expenses
OperatingExpenses
330359000 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-50303000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-27603000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-111422000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-85979000 usd
CY2024Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
6456000 usd
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
1717000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
16198000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
4619000 usd
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
3329000 usd
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
927000 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
9501000 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
2709000 usd
CY2024Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2023Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-7589000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1182000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-108000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
772000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-143000 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4309000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
682000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-120000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1767000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-45994000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-26921000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-111542000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-84212000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
188000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
195000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
414000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
495000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-46182000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-27116000 usd
us-gaap Net Income Loss
NetIncomeLoss
-111956000 usd
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.48
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.48
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.89
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.89
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.59
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.59
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.78
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.78
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31262000 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31262000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30607000 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30607000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31147000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31147000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30470000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30470000 shares
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-46182000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-27116000 usd
us-gaap Net Income Loss
NetIncomeLoss
-111956000 usd
us-gaap Net Income Loss
NetIncomeLoss
-84707000 usd
CY2024Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
13000 usd
CY2023Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
63000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-47000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
351000 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-261000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
74000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
93000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
30000 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-46430000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-26979000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-111910000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-84326000 usd
us-gaap Profit Loss
ProfitLoss
-111956000 usd
us-gaap Profit Loss
ProfitLoss
-84707000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
15426000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
11434000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
59970000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
53358000 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
1236000 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
3627000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
3747000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
4243000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
2173000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
12000 usd
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
1059000 usd
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
0 usd
irtc Provision For Credit Losses And Contractual Allowance
ProvisionForCreditLossesAndContractualAllowance
52737000 usd
irtc Provision For Credit Losses And Contractual Allowance
ProvisionForCreditLossesAndContractualAllowance
51655000 usd
us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
32069000 usd
us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-7589000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
641000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
217000 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-378000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
68680000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
51804000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1041000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1885000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-8165000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1549000 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
614000 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
21796000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-8379000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
10605000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-275000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
332000 usd
irtc Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-5336000 usd
irtc Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-3792000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-15842000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-34129000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
27098000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
26907000 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
2426000 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
109202000 usd
irtc Proceeds From Maturities Prepayments And Calls Of Marketable Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfMarketableSecurities
98700000 usd
irtc Proceeds From Maturities Prepayments And Calls Of Marketable Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfMarketableSecurities
136500000 usd
irtc Payments To Acquire Strategic Investments
PaymentsToAcquireStrategicInvestments
55000000 usd
irtc Payments To Acquire Strategic Investments
PaymentsToAcquireStrategicInvestments
3000000 usd
us-gaap Payments To Acquire In Process Research And Development
PaymentsToAcquireInProcessResearchAndDevelopment
15000000 usd
us-gaap Payments To Acquire In Process Research And Development
PaymentsToAcquireInProcessResearchAndDevelopment
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-824000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2609000 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
661250000 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 usd
irtc Purchases Of Capped Calls Transactions
PurchasesOfCappedCallsTransactions
72407000 usd
irtc Purchases Of Capped Calls Transactions
PurchasesOfCappedCallsTransactions
0 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
25000000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
5486000 usd
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
5352000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
508394000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5352000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-8000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
32000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
491720000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-31354000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
36173000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
78832000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
527893000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
47478000 usd
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
519535000 usd
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
519535000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
47478000 usd
CY2024Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
8358000 usd
CY2023Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
0 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
527893000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
47478000 usd
us-gaap Interest Paid Net
InterestPaidNet
6389000 usd
us-gaap Interest Paid Net
InterestPaidNet
2186000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
602000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
794000 usd
us-gaap Payments For Proceeds From Tenant Allowance
PaymentsForProceedsFromTenantAllowance
-736000 usd
us-gaap Payments For Proceeds From Tenant Allowance
PaymentsForProceedsFromTenantAllowance
-1603000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
173000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
89000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
4520000 usd
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
5530000 usd
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
5596000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
210097000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
604000 usd
CY2024Q1 irtc Adjustments To Additional Paid In Capital Purchase Of Capped Call Transactions
AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactions
72407000 usd
CY2024Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
25000000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
22640000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-45667000 usd
CY2024Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-54000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
77000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
90290000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4734000 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
24001000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-20107000 usd
CY2024Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-6000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
277000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
99189000 usd
CY2024Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
148000 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
18859000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-46182000 usd
CY2024Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
13000 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-261000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
71766000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
239812000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
905000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
19899000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-39109000 usd
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
327000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
221834000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4383000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
16227000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-18482000 usd
CY2023Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-39000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-44000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
223879000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
67000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
22828000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-27116000 usd
CY2023Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
63000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
74000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
219795000 usd
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassification</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior period amounts have been reclassified to conform to the current year presentation. These reclassifications have no impact on previously reported results of operations or financial position.</span></div>
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the periods presented. On an ongoing basis, management evaluates its estimates, including those related to revenue recognition, contractual allowances, provision for credit losses, the useful lives of property and equipment, the recoverability of long-lived assets, including the estimated usage of the printed circuit board assemblies (“PCBAs”), the incremental borrowing rate for operating leases, accounting for income taxes, impairment of ROU assets, contingent consideration liabilities, and various inputs used in estimating stock-based compensation. Actual results may differ from those estimates.</span></div>
CY2024Q3 us-gaap Restricted Cash
RestrictedCash
8400000 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Risk</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to a concentration of credit risk consist primarily of cash and cash equivalents, investments and accounts receivable. Cash balances are deposited in financial institutions which, at times, may be in excess of federally insured limits. Cash equivalents are invested in highly rated money market funds. The Company invests in a variety of financial instruments, such as, but not limited to, U.S. government securities, corporate notes, commercial paper and, by policy, limits the amount of credit exposure with any one financial institution or commercial issuer. The Company has not experienced any material losses on its deposits of cash and cash equivalents or investments.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Concentrations of credit risk with respect to accounts receivable are limited due to the large number of customers comprising the Company’s customer base and their dispersion across many geographies. The Company does not require collateral. During the first quarter of 2024, the Company experienced a temporary delay in the billing of the Company's contracted and non-contracted payer customers, performed by the Company's third-party claims processing vendor. The delay was due to a cybersecurity incident experienced by Change Healthcare, a division of UnitedHealth Group, which the Company's third-party vendor engages for services relating to billing and collections. While the Company substantially cleared the billing backlog as of the end of the first quarter of 2024, the delay in billing resulted in a temporary delay in the Company's cash collections. During the second and third quarters of 2024, the Company has received a significant portion of its cash collections from the delayed billings.</span></div>The Company records a provision for credit losses based on the assessment of the collectability of customer accounts, considering factors such as historical experience, credit quality, the age of the accounts receivable balances, and current economic conditions that may affect a customer’s ability to pay.
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
147538000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
124604000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
427514000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
360170000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
20289000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
18475000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
18475000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
16242000 usd
CY2023 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
17105000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
12595000 usd
irtc Allowance For Doubtful Accounts Receivable Write Offs Net Of Recoveries And Other Adjustments
AllowanceForDoubtfulAccountsReceivableWriteOffsNetOfRecoveriesAndOtherAdjustments
14040000 usd
CY2023 irtc Allowance For Doubtful Accounts Receivable Write Offs Net Of Recoveries And Other Adjustments
AllowanceForDoubtfulAccountsReceivableWriteOffsNetOfRecoveriesAndOtherAdjustments
15291000 usd
irtc Allowance For Doubtful Accounts Receivable Write Offs Net Of Recoveries And Other Adjustments
AllowanceForDoubtfulAccountsReceivableWriteOffsNetOfRecoveriesAndOtherAdjustments
11659000 usd
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
22491000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
20289000 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
19411000 usd
CY2023Q4 irtc Accounts Receivable For Contractual Allowance
AccountsReceivableForContractualAllowance
52689000 usd
CY2022Q4 irtc Accounts Receivable For Contractual Allowance
AccountsReceivableForContractualAllowance
41389000 usd
CY2022Q4 irtc Accounts Receivable For Contractual Allowance
AccountsReceivableForContractualAllowance
41389000 usd
irtc Accounts Receivable Allowance For Contractual Adjustments
AccountsReceivableAllowanceForContractualAdjustments
36495000 usd
CY2023 irtc Accounts Receivable Allowance For Contractual Adjustments
AccountsReceivableAllowanceForContractualAdjustments
52523000 usd
irtc Accounts Receivable Allowance For Contractual Adjustments
AccountsReceivableAllowanceForContractualAdjustments
39060000 usd
irtc Accounts Receivable Contractual Adjustments
AccountsReceivableContractualAdjustments
31984000 usd
CY2023 irtc Accounts Receivable Contractual Adjustments
AccountsReceivableContractualAdjustments
41223000 usd
irtc Accounts Receivable Contractual Adjustments
AccountsReceivableContractualAdjustments
32072000 usd
CY2024Q3 irtc Accounts Receivable For Contractual Allowance
AccountsReceivableForContractualAllowance
57200000 usd
CY2023Q4 irtc Accounts Receivable For Contractual Allowance
AccountsReceivableForContractualAllowance
52689000 usd
CY2023Q3 irtc Accounts Receivable For Contractual Allowance
AccountsReceivableForContractualAllowance
48377000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
3100000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
3000000.0 usd
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3000000.0 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3300000 usd
CY2024Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
165454000 usd
CY2024Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
11000 usd
CY2024Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
2000 usd
CY2024Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
165463000 usd
CY2024Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
162967000 usd
CY2024Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
2496000 usd
CY2024Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
165463000 usd
CY2023Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
110128000 usd
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
59000 usd
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
2000 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
110185000 usd
CY2023Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
12594000 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
97591000 usd
CY2023Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
110185000 usd
CY2024Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
224522000 usd
CY2024Q3 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
17069000 usd
CY2023Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
113185000 usd
irtc Fair Value Of Strategic Investment
FairValueOfStrategicInvestment
55000000 usd
CY2024Q3 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
55600000 usd
CY2023Q4 irtc Strategic Investments
StrategicInvestments
3000000 usd
CY2024Q3 us-gaap Increase Decrease In Equity Securities Fv Ni
IncreaseDecreaseInEquitySecuritiesFvNi
500000 usd
CY2024Q3 us-gaap Inventory Work In Process And Raw Materials Net Of Reserves
InventoryWorkInProcessAndRawMaterialsNetOfReserves
6769000 usd
CY2023Q4 us-gaap Inventory Work In Process And Raw Materials Net Of Reserves
InventoryWorkInProcessAndRawMaterialsNetOfReserves
6299000 usd
CY2024Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
8263000 usd
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
7674000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
15032000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
13973000 usd
CY2024Q3 irtc Strategic Loan Investment
StrategicLoanInvestment
55563000 usd
CY2023Q4 irtc Strategic Loan Investment
StrategicLoanInvestment
0 usd
CY2024Q3 us-gaap Equity Method Investments
EquityMethodInvestments
3496000 usd
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
3000000 usd
CY2024Q3 us-gaap Long Term Investments
LongTermInvestments
59059000 usd
CY2023Q4 us-gaap Long Term Investments
LongTermInvestments
3000000 usd
CY2024Q3 irtc Printed Circuit Board Assemblies
PrintedCircuitBoardAssemblies
38608000 usd
CY2023Q4 irtc Printed Circuit Board Assemblies
PrintedCircuitBoardAssemblies
38987000 usd
CY2024Q3 irtc Cloud Computing Arrangements
CloudComputingArrangements
5612000 usd
CY2023Q4 irtc Cloud Computing Arrangements
CloudComputingArrangements
4959000 usd
CY2024Q3 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
1320000 usd
CY2023Q4 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
1093000 usd
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
45540000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
45039000 usd
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
188320000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
154617000 usd
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
65930000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
50503000 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
122390000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
104114000 usd
CY2024Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5100000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
15400000 usd
CY2023Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4100000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
11400000 usd
CY2024Q3 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
8600000 usd
us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
27500000 usd
CY2024Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
600000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
600000 usd
CY2023Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2024Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
39524000 usd
CY2023Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
47656000 usd
CY2024Q3 us-gaap Accrued Vacation Current
AccruedVacationCurrent
7110000 usd
CY2023Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
8608000 usd
CY2024Q3 irtc Accrued Expenses Current
AccruedExpensesCurrent
12845000 usd
CY2023Q4 irtc Accrued Expenses Current
AccruedExpensesCurrent
14891000 usd
CY2024Q3 irtc Claims Payable Current
ClaimsPayableCurrent
2125000 usd
CY2023Q4 irtc Claims Payable Current
ClaimsPayableCurrent
4578000 usd
CY2024Q3 irtc Accrued Employee Stock Purchase Plan Contribution
AccruedEmployeeStockPurchasePlanContribution
1963000 usd
CY2023Q4 irtc Accrued Employee Stock Purchase Plan Contribution
AccruedEmployeeStockPurchasePlanContribution
1037000 usd
CY2024Q3 irtc Accrued State Local And Foreign Taxes
AccruedStateLocalAndForeignTaxes
3662000 usd
CY2023Q4 irtc Accrued State Local And Foreign Taxes
AccruedStateLocalAndForeignTaxes
2877000 usd
CY2024Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
6729000 usd
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
3715000 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
73958000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
83362000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
3867000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
15633000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
16096000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
16492000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
16385000 usd
CY2024Q3 irtc Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
47101000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
115574000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
26033000 usd
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
89541000 usd
CY2024Q3 irtc Technology License Agreement Upfront Fee
TechnologyLicenseAgreementUpfrontFee
15000000 usd
us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
32100000 usd
CY2024Q3 us-gaap Research And Development Asset Acquired Other Than Through Business Combination Written Off
ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
32100000 usd
CY2024Q3 irtc Collaboration Agreement Additional Milestone Payments
CollaborationAgreementAdditionalMilestonePayments
1750000 usd
CY2024Q3 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
645821000 usd
CY2023Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
0 usd
CY2024Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
3273000 usd
CY2023Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
0 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
7621000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
0 usd
CY2024Q3 irtc Operating Loss Carryforwards Tax Benefit Recognized
OperatingLossCarryforwardsTaxBenefitRecognized
0 usd
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
17158000 usd
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
21008000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
59970000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
53358000 usd
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
300000 shares
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-46182000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-27116000 usd
us-gaap Net Income Loss
NetIncomeLoss
-111956000 usd
us-gaap Net Income Loss
NetIncomeLoss
-84707000 usd
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31262000 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31262000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30607000 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30607000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31147000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31147000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30470000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30470000 shares
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.48
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.48
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.89
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.89
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.59
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.59
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.78
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.78
CY2024Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7160000 shares
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3054000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7160000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3054000 shares
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001388658-24-000167-index-headers.html Edgar Link pending
0001388658-24-000167-index.html Edgar Link pending
0001388658-24-000167.txt Edgar Link pending
0001388658-24-000167-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
irtc-20240930.htm Edgar Link pending
irtc-20240930.xsd Edgar Link pending
irtc-20240930xex311.htm Edgar Link pending
irtc-20240930xex312.htm Edgar Link pending
irtc-20240930xex321.htm Edgar Link pending
irtc-projectvoyagertechnol.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
irtc-20240930_cal.xml Edgar Link unprocessable
irtc-20240930_def.xml Edgar Link unprocessable
irtc-20240930_lab.xml Edgar Link unprocessable
irtc-20240930_pre.xml Edgar Link unprocessable
irtc-20240930_htm.xml Edgar Link completed
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending